...Talacen Tablets CIV, (pentazocine hydrochloride and acetaminophen), 25mg base/650mg base, Rx only, 100 tablets, Sanofi-Aventis; NDC 0024-1937-04, Recall # D-127-2009 CODE a) b), and c) All lots within expiry; d) Batch # 70520A1, Exp. 10/10 RECALLING FIRM/MANUFACTURER Recalling...
• Pharma News
Powered By DaylifeOther company news pages:
- Abbott Labs
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Glaxo
- Roche
- J&J
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Wyeth
Sanofi-Aventis News
ORIGINAL ARTICLE: Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
...Charleston (M.R.Z.); University of Wisconsin, Madison (S.A., E.I.); Bristol-Myers Squibb, Princeton, NJ (M.D., A.P.); and Sanofi-Aventis, Bridgewater, NJ (C.S.). This article (10.1056/NEJMoa0805450) was published at www.nejm.org on November 11, 2008. Address...
Research and Markets: Competitive Landscape, Pipeline Analysis and Growth Opportunities for the Dermatology Market Outlook to 2013
...analysis - Competitive landscape - Scope and methodology - Appendix Companies Mentioned: - Stiefel Labs - J&J - Sanofi-Aventis - Novartis - GSK - Galderma - Leo Pharma - Bayer-Schering - Schering Plough - Roche's For more information...
Vivus to Roll Out Key Obesity Drug Data
...safety issues like the heart damage caused by the popular "fen-phen" diet drug combination in the 1990s. More recently, Sanofi-Aventis(SNY Quote - Cramer on SNY - Stock Picks) halted sales of the obesity drug rimonabant in Europe after regulators there concluded...
New Malcolm Berko for 12/03/2008
...percent lower. I also like BMY because there's talk on Wall Street that it could be an enticing marriage partner and that Sanofi-Aventis or Pfizer might offer a substantial dowry (guesstimate $31 per share) to take it to the altar. BMY has a panoply of great...
Hard-hit Nexen shares soar on Total bid rumours
...Nexen, the report said. It added that Total had been considering the sale of its 13-per-cent stake in pharmaceutical company Sanofi-Aventis to help finance a deal. âThe rumours are too specific not to be taken seriously,â said one investment banker who has...
Article in The Pink Sheet Describes Managed Care Payers? Expanding Healthcare Value Scrutinization of New Oncology, HIV, and Rare Disease Drugs
...maximization." Many pharma and biotech companies"such as Pfizer, GlaxoSmithKline, Novartis, Johnson & Johnson, Sanofi-Aventis, Abbott, Lilly, AstraZeneca/MedImmune, Wyeth, Roche, Takeda, Eisai, and Astellas, as well as many development-stage biotech companies,...
Cubist Pharmaceuticals Names Santosh J. Vetticaden as Senior Vice President, Clinical Development and Chief Medical Officer
...to 2003, Dr. Vetticaden was Senior Director, Global Project Team Leader, Cardiovascular, at Aventis Pharmaceuticals (now Sanofi-Aventis). From 1997 to 2000, Dr. Vetticaden was Director, Clinical Research, in the Whitehall-Robins Healthcare Division of American...
Teva profits by "flouting drug patents": report
...a high-risk strategy of flouting drug patents," writes Bloomberg News. Targets include AstraZeneca's Pulmicort asthma medicine, Sanofi-Aventis's allergy drugs Allegra-D and Nasacort, and, possibly soon, Eli Lilly's Evista osteoperosis treatment. "Teva......
Pressure on new Sanofi-Aventis chief
...Viehbacher took over as chief executive of Sanofi-Aventis yesterday amid high expectations from beleaguered investors. News of his appointment to replace Gérard Le Fur in mid-September ended months of uncertainty and lifted the French pharmaceutical group's...
Clear
Clear